Literature DB >> 2154714

Corticotropin-releasing factor differentially regulates anterior and intermediate pituitary lobe proopiomelanocortin gene transcription, nuclear precursor RNA and mature mRNA in vivo.

D J Autelitano1, M Blum, M Lopingco, R G Allen, J L Roberts.   

Abstract

The proopiomelanocortin (POMC) gene and its peptide products are under complex regulation in the pituitary by multiple hormonal, neurohormonal and neurotransmitter factors. Corticotropin-releasing factor (CRF) stimulates the release of POMC-derived peptides in both anterior and intermediate lobes of the pituitary, while having differential long-term effects on levels of POMC mRNA in the two pituitary lobes in vivo. In the present study, we have analyzed the release of POMC-derived peptides, as well as changes in POMC gene transcription, primary transcript, nuclear mRNA and cytoplasmic mRNA levels following acute and chronic in vivo CRF administration in an attempt to elucidate the mechanism whereby this tissue-specific differential regulation occurs. Subcutaneous injection of CRF led to a substantial increase in plasma adrenocorticotropin, but only a minor sustained rise in plasma alpha-melanocyte-stimulating hormone. CRF was shown to induce rapid, time-dependent increases in POMC gene transcription in both anterior and intermediate pituitary lobes, which were reflected by increases in the level of POMC primary transcript in the nucleus. POMC primary transcript remained 2-fold elevated in the anterior lobe for at least 4 h after a single injection of CRF; in contrast, CRF stimulation of POMC primary transcript in the intermediate lobe was short-lived, and had returned to control values by 60 min after injection. After 7 days of repetitive CRF administration, POMC primary transcript, mature nuclear mRNA and cytoplasmic mRNA were 2.5 to 3.0-fold elevated in the anterior pituitary.(ABSTRACT TRUNCATED AT 250 WORDS)

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 2154714     DOI: 10.1159/000125327

Source DB:  PubMed          Journal:  Neuroendocrinology        ISSN: 0028-3835            Impact factor:   4.914


  5 in total

1.  Northern analysis of gene-specific primary transcripts using synthetic oligonucleotide probes labeled at high specific activity.

Authors:  E Gauthier; P Chapdelaine; R R Tremblay; J Y Dubé
Journal:  Nucleic Acids Res       Date:  1990-12-25       Impact factor: 16.971

2.  Studies of the secretion of corticotropin-releasing factor and arginine vasopressin into the hypophysial-portal circulation of the conscious sheep. II. The central noradrenergic and neuropeptide Y pathways cause immediate and prolonged hypothalamic-pituitary-adrenal activation. Potential involvement in the pseudo-Cushing's syndrome of endogenous depression and anorexia nervosa.

Authors:  J P Liu; I J Clarke; J W Funder; D Engler
Journal:  J Clin Invest       Date:  1994-04       Impact factor: 14.808

Review 3.  Role of kappa-opioid receptors in stress and anxiety-related behavior.

Authors:  Ashlee Van't Veer; William A Carlezon
Journal:  Psychopharmacology (Berl)       Date:  2013-07-09       Impact factor: 4.530

4.  Increased glucocorticoid receptor expression and activity mediate the LPS resistance of SPRET/EI mice.

Authors:  Lien Dejager; Iris Pinheiro; Leen Puimège; Ye-Dong Fan; Lies Gremeaux; Hugo Vankelecom; Claude Libert
Journal:  J Biol Chem       Date:  2010-07-27       Impact factor: 5.157

Review 5.  Mother to infant or infant to mother? Reciprocal regulation of responsiveness to stress in rodents and the implications for humans.

Authors:  Claire-Dominique Walker; Sophie Deschamps; Karine Proulx; Mai Tu; Camilla Salzman; Barbara Woodside; Sonia Lupien; Nicole Gallo-Payet; Denis Richard
Journal:  J Psychiatry Neurosci       Date:  2004-09       Impact factor: 6.186

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.